India UDI Status: Rule 46 With Mandatory Date Pending

1. Key takeaways

The legal basis for India’s Unique Device Identification (UDI) requirement is Rule 46 of the Medical Devices Rules, 2017, which originally required devices imported into, sold in or distributed in India to carry the device identifier (DI) and the production identifier (PI) with effect from 1 January 2022. That date has been formally postponed, and as of October 2026 India has not published a new mandatory effective date. Claims circulating in Chinese-language sources that Indian UDI is already mandatory are inaccurate, and companies planning their India labelling strategy on that assumption are spending against a requirement that is not yet in force.

• Rule 46 of the MDR 2017 requires two categories of unique identification on devices: the device identifier (DI) and the production identifier (PI).
• The original effective date was 1 January 2022, applying to devices approved for import, sale or distribution in India.
• The date has been formally postponed; no new mandatory effective date has been announced.
• For global comparison, the US FDA has fully implemented UDI (Class III in 2014, Class II in 2016, Class I in 2020); China’s NMPA applied it to high-risk devices from November 2022, Class D from November 2024 and Class B from November 2028; Japan has mandated barcode labelling since December 2022.
• GS1, HIBCC and ICCBBA are the issuing agency options, and the UDI must appear on labels and packaging in both human-readable text and machine-readable (barcode or RFID) form.

2. Legal basis

The UDI framework in India is unusual in that its legal text has existed for years while its enforcement date has not arrived. Understanding which parts of the current position are law, which are industry compilation, and which are global context is essential before any labelling budget is committed, and the table below separates the three explicitly.

The distinction between the first two rows and the third is the whole point of the table: the obligation and its original date are law, but the postponement status and the global comparison come from industry compilation of third-level sources, and the absence of an announced date is itself the operative fact for planning purposes.

3. Expert insights

Insight one: treating the existence of a legal basis as evidence that the requirement is mandatory is a widespread error in Chinese-language sources. Rule 46 has been in the text of the rules since 2017, but its implementation date has been postponed. The difference between the two positions is material: the first only requires companies to be aware of the rule, while the second would directly drive procurement of labelling equipment and packaging redesign. Companies should audit which of the two positions their internal documentation actually assumes, because budgets approved on the wrong premise are difficult to recover.

Insight two: a postponement is not a cancellation. Industry analysis judges that India is moving towards the IMDRF framework, and the direction of travel is clear. Treating UDI as indefinitely postponed and doing no preparation is a bet on an outcome that is becoming progressively less plausible. The rational reading of a postponed deadline is not that the requirement has weakened, but that the runway has lengthened — which is an opportunity to prepare cheaply, not an excuse to ignore the file.

Insight three: existing GS1 coding can be reused ahead of time. Most export-oriented manufacturers have already obtained GS1 UDI codes for the US or EU markets. The same device identifier (DI) will, in all likelihood, be directly applicable in India, requiring only registration once the Indian database comes online. This means the preparation cost lies mainly in record-keeping and label layout, not in re-coding. The company that already holds GS1 identifiers is therefore closer to compliance than its spending to date suggests, and the remaining work is largely organisational.

Insight four: the position of this series. Claims retrieved during verification that Indian UDI became mandatory for Class B in June 2026 could not be matched to any corresponding notification number or original text on the CDSCO website or in the Gazette of India, and this series does not accept them. They have been entered on the pending verification list planned for this series, and readers should treat any specific enforcement date they encounter as unconfirmed until an official number can be cited.

4. Practical recommendations

• Adopt a policy of low-cost preparation without early packaging changes: build the GS1 GTIN and UDI-DI for every model into the product master data now, and reserve the UDI barcode position in the label templates, but do not print it yet.
• When India announces the mandatory date, activating the reserved template is all that remains; no packaging redesign cycle is needed, which compresses the transition to the shortest possible preparation period.
• Verify the issuing agency choice (GS1, HIBCC or ICCBBA) against the markets the product already serves, so that one identifier set covers as many jurisdictions as possible.
• Confirm internally that both presentation forms — human-readable text and machine-readable barcode or RFID — are accounted for in the reserved label layout.
• Maintain a tracking mechanism for the announcement of India’s UDI mandatory date, so that the switch is triggered by an official publication rather than by hearsay or by a competitor’s action.

This posture avoids both failure modes at once: it prevents wasted investment against a date that has not been announced, and it avoids the scramble that follows an announced date for companies that hold no identifiers and have no reserved label space.

5. Verification checklist

• ☐ The team knows that the legal basis is Rule 46 but that no mandatory date has been published
• ☐ A GS1 UDI-DI has been created for every model, even though it is not yet in use
• ☐ The label templates reserve a position for the UDI barcode
• ☐ Packaging has not been revised ahead of an unpublished rule
• ☐ A tracking mechanism for the announcement of the Indian UDI mandatory date has been set up

Regulatory information verified as of 27 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across South Asia, including India. Our team prepares dossiers to CDSCO expectations, manages SUGAM submissions and deficiency responses, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com